ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,315Medicare Part D Prescriptions Filled, Including Refills

Rank: 83 out of 1269

$526K Total Retail Price of All Prescriptions

Rank: 136 out of 1269

277 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 277 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,502 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 460 389 1 2
LISINOPRIL 348 275 2 1
LEVOTHYROXINE SODIUM 259 213 3 4
PRAVASTATIN SODIUM 246 171 4 11
OMEPRAZOLE 225 185 5 8
ATORVASTATIN CALCIUM 224 202 6 7
METFORMIN HCL 219 171 7 9
TRAMADOL HCL 217 169 8 16
METOPROLOL TARTRATE 208 200 9 6
SIMVASTATIN 185 135 10 3
GABAPENTIN 161 119 11 17
WARFARIN SODIUM 157 157 12 12
MIRTAZAPINE 142 137 13 24
TRAZODONE HCL 129 125 14 36
DONEPEZIL HCL 127 127 15 22
LOSARTAN POTASSIUM 124 107 16 15
RANITIDINE HCL 121 92 17 27
FUROSEMIDE 113 83 18 5
CARVEDILOL 109 77 19 29
GLIPIZIDE 103 61 20 37
FAMOTIDINE 99 78 21 85
PANTOPRAZOLE SODIUM 98 82 22 18
CLOPIDOGREL 93 77 23 32
AMOX TR-POTASSIUM CLAVULANATE 89 74 24 110
HYDRALAZINE HCL 89 77 24 48
AZITHROMYCIN 84 63 26 42
DIOVAN 82 63 27 35
LEVETIRACETAM 81 57 28 55
PROAIR HFA 78 40 29 61
LOVASTATIN 78 78 29 30
LACTULOSE 75 73 31 67
FLUTICASONE PROPIONATE 74 48 32 40
NAMENDA 73 72 33 38
NOVOLOG 72 58 34 82
HYDROCHLOROTHIAZIDE 68 46 35 10
OXYCODONE-ACETAMINOPHEN 64 27 S2 36 44
SERTRALINE HCL 64 60 36 23
METOPROLOL SUCCINATE 64 51 36 13
LANTUS 62 59 39 39
ALLOPURINOL 62 62 39 49
CLONIDINE HCL 61 37 41 51
ALENDRONATE SODIUM 60 50 42 28
POLYETHYLENE GLYCOL 3350 60 54 42 50
TAMSULOSIN HCL 58 57 44 31
JANTOVEN 57 57 45 52
CRESTOR 54 34 46 25
ISOSORBIDE MONONITRATE ER 54 54 46 63
WELCHOL 52 39 48 255
LOSARTAN-HYDROCHLOROTHIAZIDE 52 40 48 59
SINGULAIR 51 34 50 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.